Enliven Therapeutics shares owned by Lord, Abbett & Co
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Lord, Abbett & Co
from 13F filings
Historical chart of Lord, Abbett & Co investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Lord, Abbett & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Lord, Abbett & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $17M | 331k | 50.75 |
| 2025-03-31 | $3.9M | 197k | 19.68 |
| 2024-12-31 | $8.7M | 386k | 22.50 |
| 2024-09-30 | $8.2M | 321k | 25.41 |